{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-21-025200","form_type":"8-K","ticker":"NRC","cik":"0000070487","company_name":"NRC HEALTH","filed_at":"2021-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:15.306423+00:00","generated_at":"2026-06-28T13:25:58.761124+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"National Research Q3 revenue up 13% to $37.8M; EPS $0.38 vs $0.37","bullets":["Revenue $37.8M (+13% YoY); operating income $13.1M (+9%).","Recurring Contract Value $151.5M; Voice of Customer revenue up 20%.","Net income $9.7M vs $9.6M; diluted EPS $0.38 vs $0.37.","Cash balance $52.5M; new clients Sharp Healthcare and UConn Health."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-21-025200","json":"https://secwatch.observer/filing/0001437749-21-025200.json","markdown":"https://secwatch.observer/filing/0001437749-21-025200.md","text":"https://secwatch.observer/filing/0001437749-21-025200.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/70487/000143774921025200/0001437749-21-025200-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/70487/000143774921025200/nrc20211102_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T13:25:58.761124+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}